Last Updated : August 13, 2024
Listening to groups with whom we collaborate is a vital part of our work and we welcome your participation.
At Canada's Drug Agency, input is information, insight, or advice given to us to contribute to a review or project. Feedback is a response to a prepared proposal, literature list, draft report, or draft recommendations.
We produce a variety of reports related to health technologies, including prescription drugs and medical devices. We frequently invite feedback on this work from interested parties.
For each drug, plasma product, or cell and gene therapy reviewed in the Drug Reimbursement Review process, there is an opportunity for patient groups and clinician groups to provide input and feedback.